Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic equivalence study of mometasone lotion versus Elomet lotion in scalp seborrheic dermatitis
TCTR20220215001Phase 2Enrolling by invitation
- Sponsor
- Hoe Pharmaceuticals Sdn. Bhd.
- Start
- Feb 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mometasone, LAS 41002 in seborrheic dermatitis (SD), sponsored by Hoe Pharmaceuticals Sdn. Bhd.. Started Feb 2022; status: enrolling by invitation.
02
Drugs
mometasoneLAS 41002
03
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on TCTR20220215001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220215001.